We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Amifostine Market by Manufacturers, Countries, Type and Application, Forecast to 2027

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.

Scope of the Report:
This report focuses on the Amifostine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
400mg/Dose
500mg/Dose

Market Segment by Applications, can be divided into
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others

There are 15 Chapters to deeply display the global Amifostine market.

Chapter 1, to describe Amifostine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Amifostine, with sales, revenue, and price of Amifostine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Amifostine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Amifostine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Amifostine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview
1.1 Amifostine Introduction
1.2 Market Analysis by Type
1.2.1 400mg/Dose
1.2.2 500mg/Dose
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer Adjuvant Therapy
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Clinigen Group
2.1.1 Business Overview
2.1.2 Amifostine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sun Pharmaceutical
2.2.1 Business Overview
2.2.2 Amifostine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Taj Pharmaceuticals
2.3.1 Business Overview
2.3.2 Amifostine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merro Pharmaceutical
2.4.1 Business Overview
2.4.2 Amifostine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Amifostine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mingren Pharma
2.6.1 Business Overview
2.6.2 Amifostine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Amifostine Market Competition, by Manufacturer
3.1 Global Amifostine Sales and Market Share by Manufacturer
3.2 Global Amifostine Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Amifostine Manufacturer Market Share
3.3.2 Top 6 Amifostine Manufacturer Market Share
3.4 Market Competition Trend
4 Global Amifostine Market Analysis by Regions
4.1 Global Amifostine Sales, Revenue and Market Share by Regions
4.1.1 Global Amifostine Sales by Regions (2012-2017)
4.1.2 Global Amifostine Revenue by Regions (2012-2017)
4.2 North America Amifostine Sales and Growth (2012-2017)
4.3 Europe Amifostine Sales and Growth (2012-2017)
4.4 Asia-Pacific Amifostine Sales and Growth (2012-2017)
4.5 South America Amifostine Sales and Growth (2012-2017)
4.6 Middle East and Africa Amifostine Sales and Growth (2012-2017)
5 North America Amifostine by Countries
5.1 North America Amifostine Sales, Revenue and Market Share by Countries
5.1.1 North America Amifostine Sales by Countries (2012-2017)
5.1.2 North America Amifostine Revenue by Countries (2012-2017)
5.2 USA Amifostine Sales and Growth (2012-2017)
5.3 Canada Amifostine Sales and Growth (2012-2017)
5.4 Mexico Amifostine Sales and Growth (2012-2017)
6 Europe Amifostine by Countries
6.1 Europe Amifostine Sales, Revenue and Market Share by Countries
6.1.1 Europe Amifostine Sales by Countries (2012-2017)
6.1.2 Europe Amifostine Revenue by Countries (2012-2017)
6.2 Germany Amifostine Sales and Growth (2012-2017)
6.3 UK Amifostine Sales and Growth (2012-2017)
6.4 France Amifostine Sales and Growth (2012-2017)
6.5 Russia Amifostine Sales and Growth (2012-2017)
6.6 Italy Amifostine Sales and Growth (2012-2017)
7 Asia-Pacific Amifostine by Countries
7.1 Asia-Pacific Amifostine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Amifostine Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Amifostine Revenue by Countries (2012-2017)
7.2 China Amifostine Sales and Growth (2012-2017)
7.3 Japan Amifostine Sales and Growth (2012-2017)
7.4 Korea Amifostine Sales and Growth (2012-2017)
7.5 India Amifostine Sales and Growth (2012-2017)
7.6 Southeast Asia Amifostine Sales and Growth (2012-2017)
8 South America Amifostine by Countries
8.1 South America Amifostine Sales, Revenue and Market Share by Countries
8.1.1 South America Amifostine Sales by Countries (2012-2017)
8.1.2 South America Amifostine Revenue by Countries (2012-2017)
8.2 Brazil Amifostine Sales and Growth (2012-2017)
8.3 Argentina Amifostine Sales and Growth (2012-2017)
8.4 Columbia Amifostine Sales and Growth (2012-2017)
9 Middle East and Africa Amifostine by Countries
9.1 Middle East and Africa Amifostine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Amifostine Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Amifostine Revenue by Countries (2012-2017)
9.2 Saudi Arabia Amifostine Sales and Growth (2012-2017)
9.3 UAE Amifostine Sales and Growth (2012-2017)
9.4 Egypt Amifostine Sales and Growth (2012-2017)
9.5 Nigeria Amifostine Sales and Growth (2012-2017)
9.6 South Africa Amifostine Sales and Growth (2012-2017)
10 Global Amifostine Market Segment by Type
10.1 Global Amifostine Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Amifostine Sales and Market Share by Type (2012-2017)
10.1.2 Global Amifostine Revenue and Market Share by Type (2012-2017)
10.2 400mg/Dose Sales Growth and Price
10.2.1 Global 400mg/Dose Sales Growth (2012-2017)
10.2.2 Global 400mg/Dose Price (2012-2017)
10.3 500mg/Dose Sales Growth and Price
10.3.1 Global 500mg/Dose Sales Growth (2012-2017)
10.3.2 Global 500mg/Dose Price (2012-2017)
11 Global Amifostine Market Segment by Application
11.1 Global Amifostine Sales Market Share by Application (2012-2017)
11.2 Ovarian Cancer Adjuvant Therapy Sales Growth (2012-2017)
11.3 Head and Neck Cancer Adjuvant Therapy Sales Growth (2012-2017)
11.4 Others Sales Growth (2012-2017)
12 Amifostine Market Forecast (2017-2022)
12.1 Global Amifostine Sales, Revenue and Growth Rate (2017-2022)
12.2 Amifostine Market Forecast by Regions (2017-2022)
12.2.1 North America Amifostine Market Forecast (2017-2022)
12.2.2 Europe Amifostine Market Forecast (2017-2022)
12.2.3 Asia-Pacific Amifostine Market Forecast (2017-2022)
12.2.4 South America Amifostine Market Forecast (2017-2022)
12.2.5 Middle East and Africa Amifostine Market Forecast (2017-2022)
12.3 Amifostine Market Forecast by Type (2017-2022)
12.4 Amifostine Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Amifostine Picture
Table Product Specifications of Amifostine
Figure Global Sales Market Share of Amifostine by Types in 2016
Table Amifostine Types for Major Manufacturers
Figure 400mg/Dose Picture
Figure 500mg/Dose Picture
Table Amifostine Sales Market Share by Applications in 2016
Figure Ovarian Cancer Adjuvant Therapy Picture
Figure Head and Neck Cancer Adjuvant Therapy Picture
Figure Others Picture
Figure USA Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure France Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure UK Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure China Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure India Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Amifostine Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Amifostine Revenue (Value) and Growth Rate (2012-2022)
Table Clinigen Group Basic Information, Manufacturing Base and Competitors
Table Clinigen Group Amifostine Type and Applications
Table Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Amifostine Type and Applications
Table Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Amifostine Type and Applications
Table Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Merro Pharmaceutical Amifostine Type and Applications
Table Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Luye Pharma Basic Information, Manufacturing Base and Competitors
Table Luye Pharma Amifostine Type and Applications
Table Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mingren Pharma Basic Information, Manufacturing Base and Competitors
Table Mingren Pharma Amifostine Type and Applications
Table Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Amifostine Sales by Manufacturer (2016-2017)
Figure Global Amifostine Sales Market Share by Manufacturer in 2016
Figure Global Amifostine Sales Market Share by Manufacturer in 2017
Table Global Amifostine Revenue by Manufacturer (2016-2017)
Figure Global Amifostine Revenue Market Share by Manufacturer in 2016
Figure Global Amifostine Revenue Market Share by Manufacturer in 2017
Figure Global Amifostine Sales and Growth (2012-2017)
Figure Global Amifostine Revenue and Growth (2012-2017)
Table Global Amifostine Sales by Regions (2012-2017)
Table Global Amifostine Sales Market Share by Regions (2012-2017)
Table Global Amifostine Revenue by Regions (2012-2017)
Table Global Amifostine Revenue Market Share by Regions in 2012
Table Global Amifostine Revenue Market Share by Regions in 2016
Figure North America Amifostine Sales and Growth (2012-2017)
Figure Europe Amifostine Sales and Growth (2012-2017)
Figure Asia-Pacific Amifostine Sales and Growth (2012-2017)
Figure South America Amifostine Sales and Growth (2012-2017)
Figure Middle East and Africa Amifostine Sales and Growth (2012-2017)
Figure North America Amifostine Revenue and Growth (2012-2017)
Table North America Amifostine Sales by Countries (2012-2017)
Table North America Amifostine Sales Market Share by Countries (2012-2017)
Figure North America Amifostine Sales Market Share by Countries in 2012
Figure North America Amifostine Sales Market Share by Countries in 2016
Table North America Amifostine Revenue by Countries (2012-2017)
Table North America Amifostine Revenue Market Share by Countries (2012-2017)
Figure North America Amifostine Revenue Market Share by Countries in 2012
Figure North America Amifostine Revenue Market Share by Countries in 2016
Figure USA Amifostine Sales and Growth (2012-2017)
Figure Canada Amifostine Sales and Growth (2012-2017)
Figure Mexico Amifostine Sales and Growth (2012-2017)
Figure Europe Amifostine Revenue and Growth (2012-2017)
Table Europe Amifostine Sales by Countries (2012-2017)
Table Europe Amifostine Sales Market Share by Countries (2012-2017)
Table Europe Amifostine Revenue by Countries (2012-2017)
Table Europe Amifostine Revenue Market Share by Countries in 2012
Table Europe Amifostine Revenue Market Share by Countries in 2016
Figure Germany Amifostine Sales and Growth (2012-2017)
Figure UK Amifostine Sales and Growth (2012-2017)
Figure France Amifostine Sales and Growth (2012-2017)
Figure Russia Amifostine Sales and Growth (2012-2017)
Figure Italy Amifostine Sales and Growth (2012-2017)
Figure Asia-Pacific Amifostine Revenue and Growth (2012-2017)
Table Asia-Pacific Amifostine Sales by Countries (2012-2017)
Table Asia-Pacific Amifostine Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Amifostine Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Amifostine Revenue by Countries (2012-2017)
Table Asia-Pacific Amifostine Revenue Market Share by Countries (2012-2017)
Figure China Amifostine Sales and Growth (2012-2017)
Figure Japan Amifostine Sales and Growth (2012-2017)
Figure Korea Amifostine Sales and Growth (2012-2017)
Figure India Amifostine Sales and Growth (2012-2017)
Figure Southeast Asia Amifostine Sales and Growth (2012-2017)
Figure South America Amifostine Revenue and Growth (2012-2017)
Table South America Amifostine Sales by Countries (2012-2017)
Table South America Amifostine Sales Market Share by Countries (2012-2017)
Figure South America Amifostine Sales Market Share by Countries in 2016
Table South America Amifostine Revenue by Countries (2012-2017)
Table South America Amifostine Revenue Market Share by Countries (2012-2017)
Figure South America Amifostine Revenue Market Share by Countries in 2012
Figure South America Amifostine Revenue Market Share by Countries in 2016
Figure Brazil Amifostine Sales and Growth (2012-2017)
Figure Argentina Amifostine Sales and Growth (2012-2017)
Figure Columbia Amifostine Sales and Growth (2012-2017)
Figure Middle East and Africa Amifostine Revenue and Growth (2012-2017)
Table Middle East and Africa Amifostine Sales by Countries (2012-2017)
Table Middle East and Africa Amifostine Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Amifostine Sales Market Share by Countries in 2016
Table Middle East and Africa Amifostine Revenue by Countries (2012-2017)
Table Middle East and Africa Amifostine Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Amifostine Revenue Market Share by Countries in 2012
Figure Middle East and Africa Amifostine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Amifostine Sales and Growth (2012-2017)
Figure UAE Amifostine Sales and Growth (2012-2017)
Figure Egypt Amifostine Sales and Growth (2012-2017)
Figure Nigeria Amifostine Sales and Growth (2012-2017)
Figure South Africa Amifostine Sales and Growth (2012-2017)
Table Global Amifostine Sales by Type (2012-2017)
Table Global Amifostine Sales Share by Type (2012-2017)
Table Global Amifostine Revenue by Type (2012-2017)
Table Global Amifostine Revenue Share by Type (2012-2017)
Figure Global 400mg/Dose Sales Growth (2012-2017)
Figure Global 400mg/Dose Price (2012-2017)
Figure Global 500mg/Dose Sales Growth (2012-2017)
Figure Global 500mg/Dose Price (2012-2017)
Table Global Amifostine Sales by Application (2012-2017)
Table Global Amifostine Sales Share by Application (2012-2017)
Figure Global Ovarian Cancer Adjuvant Therapy Sales Growth (2012-2017)
Figure Global Head and Neck Cancer Adjuvant Therapy Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Amifostine Sales, Revenue and Growth Rate (2017 -2022)
Table Global Amifostine Sales Forecast by Regions (2017-2022)
Table Global Amifostine Market Share Forecast by Regions (2017-2022)
Figure North America Sales Amifostine Market Forecast (2017-2022)
Figure Europe Sales Amifostine Market Forecast (2017-2022)
Figure Asia-Pacific Sales Amifostine Market Forecast (2017-2022)
Figure South America Sales Amifostine Market Forecast (2017-2022)
Figure Middle East and Africa Sales Amifostine Market Forecast (2017-2022)
Table Global Amifostine Sales Forecast by Type (2017-2022)
Table Global Amifostine Market Share Forecast by Type (2017-2022)
Table Global Amifostine Sales Forecast by Application (2017-2022)
Table Global Amifostine Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved